rs10010131A in WFS1 is Associated with Elevated Serum Urea in Type 2 Diabetes Patients Treated with SGLT2 Inhibitors
Therapeutics and Clinical Risk Management · 2026-04 · Volume 22 · 1-9
DOI: 10.2147/tcrm.s578286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutics and Clinical Risk Management, 2026-04. Verfasst von Khaled Naja und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research Center, QU Health, Qatar University, Doha, Qatar. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biomedical Research Center, QU Health, Qatar University, Doha, Qatar.
- Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
- School of Medicine, Promise Department, University of Palermo, Palermo, Italy.
- Department of Medicine, Ras Al Khaimah (RAK) Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.
- College of Medicine, QU Health, Qatar University, Doha, Qatar.
ORCID-Profile: Khaled Naja, Laila Hedaya, Najeha Rizwana Anwardeen, Manfredi Rizzo
Zitieren
APA
Naja, K., Elashi, A. A., Hedaya, L., Anwardeen, N. R., Al-Shafai, M., Rizzo, M., & Elrayess, M. A. (2026). rs10010131A in WFS1 is Associated with Elevated Serum Urea in Type 2 Diabetes Patients Treated with SGLT2 Inhibitors. Therapeutics and Clinical Risk Management, Volume 22, 1-9. https://doi.org/10.2147/tcrm.s578286
Vancouver
Naja K, Elashi AA, Hedaya L, Anwardeen NR, Al-Shafai M, Rizzo M, et al. rs10010131A in WFS1 is Associated with Elevated Serum Urea in Type 2 Diabetes Patients Treated with SGLT2 Inhibitors. Therapeutics and Clinical Risk Management. 2026;Volume 22:1-9. doi:10.2147/tcrm.s578286
BibTeX
@article{Naja2026,
author = {Naja, Khaled and Elashi, Asma A and Hedaya, Laila and Anwardeen, Najeha Rizwana and Al-Shafai, Mashael and Rizzo, Manfredi and Elrayess, Mohamed A},
title = {rs10010131A in WFS1 is Associated with Elevated Serum Urea in Type 2 Diabetes Patients Treated with SGLT2 Inhibitors},
journal = {Therapeutics and Clinical Risk Management},
year = {2026},
volume = {Volume 22},
pages = {1--9},
doi = {10.2147/tcrm.s578286}
}
EUVIMED